Warby Parker
- Market cap
- 3.13B
- P/E (TTM)i
- 421.83
- P/Bi
- 7.98
- EPSi
- 0.01
- Div yieldi
- 0.00%
- 52W posi
- 65%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.3 percentage points.
Institutional ownership
- Held by institutions
- 102.13% -0.30pp
- Institutions
- 358 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 18 buys · 32 sells
| Name | Role | Stake |
|---|---|---|
| Neil Blumenthal | Co-Founder, President, Co-CEO & Co-Chair | 6.18% |
| David Gilboa | Co-Founder, Co-CEO & Co-Chair | 5.08% |
| Andrew Hunt | Co-Founder & Independent Director | 1.57% |
| Jeff Raider | Co-Founder & Independent Director | 0.34% |
| Steve Miller | Chief Financial Officer | 0.19% |
| Joel Cutler | Independent Director | 0.11% |
| Bradley Singer | Independent Director | 0.08% |
| Teresa Briggs | Independent Director | 0.05% |
| Ronald Williams | Independent Director | 0.02% |
| Youngme Moon | Independent Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Jeff Raider | Co-Founder & Independent Director | Automatic Disposition | -15,000 | $27.70 |
| 2026-09-30 | Neil Blumenthal | Co-Founder, President, Co-CEO & Co-Chair | Automatic Disposition | -4,386 | $27.69 |
| 2026-09-30 | Neil Blumenthal | Co-Founder, President, Co-CEO & Co-Chair | Derivative Exercise and Sale | -95,614 | $27.69 |
| 2026-09-01 | Neil Blumenthal | Co-Founder, President, Co-CEO & Co-Chair | Derivative Exercise and Sale | -23,637 | $24.19 |
| 2026-09-01 | Neil Blumenthal | Co-Founder, President, Co-CEO & Co-Chair | Derivative Exercise and Sale | -11,504 | $24.19 |
| 2026-09-01 | Neil Blumenthal | Co-Founder, President, Co-CEO & Co-Chair | Derivative Exercise and Retained | +9,294 | -- |
| 2026-09-01 | Neil Blumenthal | Co-Founder, President, Co-CEO & Co-Chair | Derivative Exercise and Retained | +21,003 | -- |
| 2026-09-01 | David Gilboa | Co-Founder, Co-CEO & Co-Chair | Derivative Exercise and Sale | -23,637 | $24.19 |
| 2026-09-01 | David Gilboa | Co-Founder, Co-CEO & Co-Chair | Derivative Exercise and Sale | -11,504 | $24.19 |
| 2026-09-01 | David Gilboa | Co-Founder, Co-CEO & Co-Chair | Derivative Exercise and Retained | +9,294 | -- |
| 2026-09-01 | David Gilboa | Co-Founder, Co-CEO & Co-Chair | Derivative Exercise and Retained | +21,003 | -- |
| 2026-08-11 | Neil Blumenthal | Co-Founder, President, Co-CEO & Co-Chair | Derivative Exercise and Retained | +200,000 | $3.83 |
| 2026-07-05 | Neil Blumenthal | Co-Founder, President, Co-CEO & Co-Chair | Derivative Exercise and Sale | -9,200 | $29.99 |
| 2026-07-05 | David Gilboa | Co-Founder, Co-CEO & Co-Chair | Derivative Exercise and Sale | -54,347 | -- |
| 2026-06-30 | Jeff Raider | Co-Founder & Independent Director | Automatic Disposition | -22,500 | $29.72 |
| 2026-06-30 | Neil Blumenthal | Co-Founder, President, Co-CEO & Co-Chair | Automatic Disposition | -28,347 | $29.61 |
| 2026-06-30 | Neil Blumenthal | Co-Founder, President, Co-CEO & Co-Chair | Derivative Exercise and Sale | -189,320 | $29.61 |
| 2026-06-30 | David Gilboa | Co-Founder, Co-CEO & Co-Chair | Other Disposition | -96,525 | -- |
| 2026-06-30 | David Gilboa | Co-Founder, Co-CEO & Co-Chair | Automatic Disposition | -28,475 | $29.69 |
| 2026-06-30 | David Gilboa | Co-Founder, Co-CEO & Co-Chair | Derivative Exercise and Sale | -213,746 | $29.69 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:40:26 · For reference only, not investment advice and not tailored to your situation.